Clinical Researchers

Alicia Parker, M.D.



Research Areas
Clinical Research


Tiffany F. Kautz, Ph.D.

Research focuses upon identifying biomarkers for earlier identification of Alzheimer’s disease and related neurodegenerative diseases. Actively involved in coordinating research collaborations to further these research interests, including the Markers for Vascular Contributions to Cognitive Impairment and Dementia (MarkVCID) and Cognitively Healthy Nonagenarians in the Cross Cohort Collaboration (CCC). Also serves as the creator and coordinator of the Biggs Biobank, a comprehensive repository of biofluids and tissues from a variety of neurodegenerative disorders as well as cognitively healthy controls.



Research Areas
Clinical Research


Mini E. Jacob, M.D., Ph.D.

Research focuses on the process of disablement among older adults, particularly on the intertwining pathways to mobility disability and dementia. Previous studies evaluated whether behavioral factors like diet and physical activity in early old age can continue to influence health and affect the length of terminal morbidity and disability. Ongoing projects examine patterns and burden of multi-morbidity as a risk factor for disablement, the role of cognitive impairment in the pathway to disability and how a combination of physical and cognitive impairment can influence disablement. Current objectives also include evaluating how physical function measures correlate with markers of Alzheimer’s disease in asymptomatic individuals and identifying mobility measures that reflect brain vascular pathology.



Research Areas
Clinical Research, Population Neuroscience


Mitzi M. Gonzales, Ph.D., ABPP-CN

Research broadly focuses on identifying mechanisms and biomarkers of advanced age-related cognitive decline and dementia in effort to aid timely diagnosis, prevent progression and advance treatment discovery. This research leverages clinical neuropsychology, structural and functional neuroimaging and genomics. A primary aim is to understand the underlying mechanisms linking cardiovascular disease with increased dementia risk and develop interventions that slow the rate of cognitive decline.



Research Areas
Clinical Research, Population Neuroscience